University at Buffalo neuroscientists have identified the binding site of low-dose ketamine, providing critical insight into how the medication, often described as a wonder drug, alleviates symptoms of major depression in as little as a few hours with effects lasting for several days.
House Committee Divided on Whether Changes are Needed in 340B Drug Discount Program
House members generally expressed support Tuesday for the 340B drug discount program that serves hospitals and clinics treating low-income patients, but disagreed on whether the
June 5, 2024